Sunil Prabhu

Sunil Prabhu, BPharm, PhD, is the Dean and Professor at the College of Pharmacy, Western University of Health Sciences. He specializes in Biotechnology and Pharmaceutical Sciences with a focus on novel drug delivery systems, nanotechnology, and cancer chemoprevention.

Education:

• Management Development Program, Harvard Graduate School of Education (HGSE), June 2023
• Academic Leadership Certification, Haas School of Business, University of California, Berkeley, 2012
• AACP Fellow, Academic Leaders Fellowship Program (ALFP), 2009
• Doctor of Philosophy (PhD), Pharmaceutics, West Virginia University, 1996
• Bachelor of Pharmacy (B.Pharm), Birla Institute of Technology, India, 1987

Research Interests:

Dr. Prabhu's research is centered on the formulation development of novel drug delivery systems, particularly leveraging nanotechnology for controlled release and targeted therapy. His work extensively explores cancer chemoprevention, especially in pancreatic and colon cancers, using combinatorial regimens and nano-drug systems.

Awards & Recognition:

• AACP Fellow, Academic Leaders Fellowship Program (ALFP), 2009

Research Grants & Funding:

• Principal Investigator, NIH/NCI R15: "Combinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention" (2014–2017)
• Principal Investigator, NIH/NCI R03: "Chemoprevention of pancreatic cancer using a combinatorial nano-drug system" (2011–2013)
• Principal Investigator, NIH/NCI R03: "Combined Chemoprevention Using A Nanotechnology-based Therapeutic System" (2007–2010)